Myalgic encephalomyelitis (ME) / Chronic fatigue syndrome (CFS) is a debilitating neurological condition marked by severe fatigue, immune dysfunction, and autonomic nervous system disorders. Despite the complexity and severity of ME/CFS, treatment options remain limited, with Cognitive Behavioral Therapy (CBT) and Graded Exercise Therapy (GET) commonly prescribed. This review critically examines the ethical implications of standardizing CBT and GET as treatments for ME/CFS. Highlighting the diverse patient responses and potential harm, the review argues for a more individualized approach to therapy. It underscores the urgent need for extensive research into ME/CFS and advocates for comprehensive support from the healthcare system to better address this challenging condition.
Table of Contents
1. Abstract
2. Background
2.1. Myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS)
2.2. Prevalence
2.3. Etiology
2.4. Diagnostics
2.5. State of Research
3. Treatments
3.1. Health Promotion
3.2. Cognitive Behavioral Therapy (CBT)
3.3. Graded Exercise Therapy (GET)
4. Discussion
4.1. Ethical Principles in Health Promotion
4.2. Current Treatment Recommendation
4.3. Treatment with CBT
4.4. Combined Standardized Treatment with CBT and GET
4.5. Positive Impact of CBT/GET Therapy
4.6. Negative Impact of CBT/GET Therapy
4.7. Elimination of Ethical Problems
5. Conclusion
6. References
Research Objectives and Themes
This paper critically examines the ethics of standardizing Cognitive Behavioral Therapy (CBT) and Graded Exercise Therapy (GET) as primary interventions for patients suffering from Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS).
- Analysis of ME/CFS clinical characteristics and current research gaps.
- Evaluation of standardized CBT and GET protocols against health promotion ethics.
- Review of conflicting clinical study results regarding the efficacy of CBT and GET.
- Identification of potential physical and psychological burdens caused by standardized therapy.
- Proposals for patient-centric and multidisciplinary support strategies.
Excerpt from the Book
4.4. Combined Standardized Treatment with CBT and GET
Current studies show contradictory results. A study by Maes & Twisk (2009) proves that the combination of CBT and GET is not effective. The treatment is partially not only ineffective, it even worsens the patients’ health status (Maes M & Twisk-FN, 2009). Another study supports this result. It concluded that 51% of respondents had worsened health status with GET and 20% of study participants had worsened health status after CBT (Kindlon, n. D., p. 60) .
Other studies, such as the PACE study (Sharpe et al. 2015), confirm the positive effects of CBT and GET and demonstrate that there is no scientific evidence regarding worsening health status. According to the evidence, the treatment even improves the health status in terms of exhaustion and physical impairments in the long term, which was evaluated during a follow-up. The authors concluded that the improvement persisted 2 years after completion of treatment (Sharpe et al., 2015, p. 1072-1073) However, the study has been controversial among some researchers like Geraghty, 2016; Marks, 2017; Wilshire et al., 2018 because of methods (Van Damme S., Maes S., 2021).
The authors of the PACE study were accused by Marks (2017) of having a conflict of interest because they developed GET and CBT for CFS/ME. They also work for the UK Department for Work and Pensions (DWP). This acted as sponsor for the PACE study. They also act as consultants to major insurance companies. Classification of CFS/ME as a chronic physical illness could lead to financial losses for the authors of the PACE study. In addition, there was a lack of willingness on the part of the lead authors to take a stand, which is why the study results are even more questioned.
Summary of Chapters
1. Abstract: Provides an overview of ME/CFS as a complex neurological disease and highlights the ethical controversy regarding standard CBT/GET treatment.
2. Background: Defines ME/CFS, its prevalence, etiological hypotheses, current diagnostic challenges, and the significant lack of research funding.
3. Treatments: Explains the concepts of health promotion, CBT, and GET, outlining their intended roles in managed care settings.
4. Discussion: Evaluates ethical principles in light of current treatment guidelines, dissects contradictory clinical trial results, and analyzes the negative impacts on patients.
5. Conclusion: Summarizes the necessity for individualized patient care, multidisciplinary cooperation, and the urgent need for new research into disease-specific treatments.
6. References: Compiles all academic citations and sources used to evaluate the clinical and ethical arguments.
Keywords
ME/CFS, Myalgic Encephalomyelitis, Chronic Fatigue Syndrome, Cognitive Behavioral Therapy, Graded Exercise Therapy, Health Promotion, Ethics, PACE study, Post-exertional malaise, Patient Care, Medical Research, Resilience, Healthcare System, Clinical Trials, Symptom Exacerbation
Frequently Asked Questions
What is the core focus of this publication?
The paper focuses on the ethical implications of using standard Cognitive Behavioral Therapy (CBT) and Graded Exercise Therapy (GET) as the default treatment for patients diagnosed with ME/CFS.
What are the primary themes addressed regarding the disease?
The central themes include the clinical complexity of ME/CFS, the diagnostic difficulties patients face, the research funding gaps, and the debate surrounding therapeutic efficacy.
What is the main research question or goal?
The goal is to determine if current standardized therapy recommendations for ME/CFS are ethically justifiable given the patient reports of symptom worsening and the existence of conflicting academic evidence.
Which methodologies were applied in this work?
The author conducted a literature review and synthesis of clinical studies, including large-scale trials like the PACE study, to perform an ethical evaluation based on health promotion principles.
What topics are covered in the main body section?
The main body covers the medical definition of ME/CFS, the definitions and practices of CBT/GET, an ethical discussion of current guidelines, and a detailed analysis of both positive and negative treatment outcomes.
Which key terms characterize the study?
Key terms include ME/CFS, patient autonomy, standardized vs. individualized treatment, ethical intervention, and medical research gaps.
How does the PACE study influence the discussion of therapy?
The PACE study is a central point of contention; while it presents positive long-term outcomes to justify CBT and GET, the paper highlights how this study has been heavily criticized for methodological flaws and conflicts of interest among its authors.
Why does the author argue that standardized treatment may be harmful?
The author identifies that standardized application ignores individual variability and can lead to symptom exacerbation (PEM), treatment as an added burden, and psychological harm, such as feelings of guilt and failure, when patients are unable to comply with the treatment schedule.
What potential future hope for patients is mentioned?
The author highlights research into the cardiac drug BC007, which shows initial promise in potentially treating underlying mechanisms in post-covid syndrome, which may share parallels with ME/CFS pathology.
- Quote paper
- Sandra Pollan (Author), 2022, Ethical Considerations of CBT and GET in Treating ME/CFS. A Comprehensive Review, Munich, GRIN Verlag, https://www.hausarbeiten.de/document/1490463
